COMMUNIQUÉS West-GlobeNewswire

Ronald McDonald House Charities Named Title Partner of the 2019 Triple-A All-Star Game
26/06/2019
The 2019 RMHC Triple-A All-Star Game & Jarritos Triple-A Home Run Derby will take place atSouthwest University Park July 8-10. El Paso, TX, June 26, 2019 (GLOBE NEWSWIRE) -- The El Paso Chihuahuas announced today [...]
HydraFacial MD® Now Available with Dr. Samuel Hahn
26/06/2019
MD Center for Facial Plastic Surgery now provides HydraFacial® treatments for men and women in Baltimore, MD BALTIMORE, June 26, 2019 (GLOBE NEWSWIRE) -- Maryland Center for Facial Plastic Surgery now proudly offers the [...]
OmniSeq Board Names Margot Schoenborn to Succeed Mark Gardner as CEO
26/06/2019
BUFFALO, N.Y., June 26, 2019 (GLOBE NEWSWIRE) -- OmniSeq, Inc. named Margot P. Schoenborn to succeed Mark Gardner as the chief executive officer of the molecular diagnostics and precision medicine company. “We’re [...]
LifePod Announces Early Access to First Proactive-Voice Virtual Caregiver Service for Older Adults and Chronic Care Patients at Home
26/06/2019
Extends Remote, Personalized Care and Emotional Support to over 117 Million Americans Aging at Home or Dealing with Chronic Conditions BOSTON, June 26, 2019 (GLOBE NEWSWIRE) -- Winner of the Best of Show award in [...]
Copeland Biosciences Corp. Retains KCSA Strategic Communications as Corporate Communications Counsel
26/06/2019
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- Copeland Biosciences Corp , a cannabis pharma company that provides safe and effective remedies to relieve inflammatory pain with propriety formulations in conjunction with [...]
Fagron NV: Fagron reaches settlement in principle with US Department of Justice
26/06/2019
Regulated information - Inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 June 2019 - 15:00 CEST Fagron reaches settlement in principle with US Department of Justice Fagron announced today that it [...]
BioPorto Appoints New Chief Medical Officer
26/06/2019
June 26, 2019 News release BioPorto Appoints New Chief Medical Officer In preparation to fully leverage its biomarker technology, BioPorto further strengthens global leadership team Today, BioPorto A/S CPH:BIOPOR (“ [...]
Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix
26/06/2019
MIRAMAR, Fla., June 26, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ), announced today that their subsidiary, Olaregen Therapeutix, [...]
Y-mAbs Announces Data to be Presented at 2019 SIOP
26/06/2019
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Golden Leaf Holdings Ltd. Announces Election of New Board of Directors, Approval of Amendment to Terms of Debenture Indenture for Debentures Maturing November 2, 2019 and Release of Slide Presentation
26/06/2019
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” of the “Company”), a cannabis company with cultivation, production and retail operations built around [...]
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
26/06/2019
SOUTH SAN FRANCISCO, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Driven Deliveries Inc. Announces Partnership with Cypress Hill Rapper, B-Real’s, Dr. Greenthumb’s Dispensary
26/06/2019
SAN DIEGO, June 26, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc. (DRVD), the world’s first publicly traded cannabis delivery company, announced today that they have partnered with Dr. Greenthumb’s Dispensary to [...]
Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo® (nivolumab) Phase 1 Combination Trial in Brain Cancer
26/06/2019
– Enrollment completed in third cohort of dose-escalation study at leading brain cancer hospitals in US; Investigators indicate interest in expanding study – BOSTON, June 26, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology [...]
Letter to Shareholders from Curt Fairbrother, CEO
26/06/2019
CORONA, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Dear Shareholders: The filing delay for our 10K and 10Q will be coming to an end shortly. I wanted to take this opportunity first to assure you that the reason for the [...]
CorMedix Inc. Set to Join the Russell 2000® Index
26/06/2019
BERKELEY HEIGHTS, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
XBiotech Wins “Commercial Real Estate Award for Industrial Development” for its Headquarters in Austin, Texas
26/06/2019
AUSTIN, Texas, June 26, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that it is the recipient of the first place 2019 Commercial Real Estate Award for Industrial Development, chosen by the [...]
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
26/06/2019
Both Phase 3 TRILOGY studies at 100% randomization >60% of patients have completed the 6-month trial Release of topline results remain on track Fully funded beyond completion of Phase 3 studies Conference call to be [...]
Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783 on Alcohol-Seeking Behavior and Relapse-Like Behavior in Multiple Models of Alcohol Use Disorder
26/06/2019
EVANSTON, Ill., June 26, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
26/06/2019
EAST RUTHERFORD, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

Pages